NewzCLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Thursday reported a second-quarter loss of $20.2 million, after reporting a profit in the same period a year earlier. The Cleveland-based company said it had a loss of 35 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share. The drug developer posted revenue of $11.4 million in the period, also falling short of Street forecasts.
Four analysts surveyed by Zacks expected $13.1 million. Abeona Therapeutics shares have risen 42% since the beginning of the year. The stock has increased 17% in the last 12 months.
_____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO Source NEW YORK (AP) — NEW YORK (AP) — The Madison Square Garden Co.
(MSGS) on Thursday reported fiscal fourth-quarter profit of $28.3 million. On a per-share basis, the New York-based company said it had net income of $1.16. Earnings, adjusted for restructuring costs, were $1.19 per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 72 cents per share. The sports team and entertainment company posted revenue of $278.7 million in the period, also surpassing Street forecasts.
Summary from source